March 2026 News Bulletin

WE’RE EXHIBITING AT MAKING PHARMACEUTICALS 2026

Join us at Stand 611 at Making Pharmaceuticals 2026 

We’re excited to be exhibiting at Making Pharmaceuticals 2026, taking place at the Coventry Building Society Arena on 21–22 April 2026.

Whether you’re exploring new partnerships or looking to optimise your current testing strategy, we’d love to connect. The event is free to attend, and our team –  John Welch, Mala Patel, and Adam Dempsey – will be on hand to discuss how Butterworth Laboratories can support your analytical testing needs with quality, reliability and expertise.

To make the most of your visit, book a meeting in advance at Business@butterworth-labs.co.uk, or simply stop by Stand 611 – we look forward to seeing you there.

BALANCING INNOVATION AND ACCESSABILITY IN AMINO ACID TESTING

A short article published by Manufacturing Chemist, written by John Welch – Associate Director Business Operations, on Butterworth’s use of on using  a dedicated Amino Acid Analyser to enable them  to provide verified testing for all listed amino acids in the European Pharmacopoeia monographs.

ANALYTICAL INSIGHTS – RECENT BLOGS

We have published a number of blogs in March, including these two:

Safely Managing Highly Hazardous Reagents, Hydrofluoric Acid in Pharmacopoeia Testing 

In the world of pharmacopoeia testing, not all reagents are created equal, and some require exceptional care.  

Senior Analytical Chemist, Meghann Simcock, dives into how Butterworth Laboratories expertly handle highly hazardous reagents, such as Hydrofluoric Acid (HF), and gases, such as hydrogen sulfide and chlorine, to deliver accurate, compliant results without compromising safety.

The pMDI Propellant of Tomorrow: Regulatory History and the Emergence of HFO 1234ze(E)

The shift to climate-friendly propellants is gathering momentum, but it also increases analytical complexity and makes more demands on internal laboratory resources.

In our latest blog, Consultant Chemist – Chromatography, Frank Judge explores what this transition means and how companies can stay ahead while maintaining compliance and timelines.

To see all our Blogs and Subscribe to them, click: Here